A phase II study of bendamustine plus rituximab in Japanese patients with relapsed or refractory indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma previously treated with rituximab: BRB study

Kimihiro Matsumoto, Nobuyuki Takayama, Yoshinobu Aisa, Hironori Ueno, Masao Hagihara, Kentaro Watanabe, Aya Nakaya, Kenko Chen, Takayuki Shimizu, Yuiko Tsukada, Yuji Yamada, Tomonori Nakazato, Akaru Ishida, Yoshitaka Miyakawa, Kenji Yokoyama, Hideaki Nakajima, Yoshihiro Masuda, Takahiro Yano, Shinichiro Okamoto

Research output: Contribution to journalArticle

12 Citations (Scopus)

Fingerprint Dive into the research topics of 'A phase II study of bendamustine plus rituximab in Japanese patients with relapsed or refractory indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma previously treated with rituximab: BRB study'. Together they form a unique fingerprint.

Medicine & Life Sciences